# Black Diamond Therapeutics, Inc.: Form SC 13D/A, filed May 13, 2024

- Company: [Black Diamond Therapeutics, Inc.](/companies/bdtx.md) (CIK 1701541)
- Form: SC 13D/A
- Filed: 2024-05-13
- Accepted by EDGAR: May 13, 2024, 19:09 ET
- Period: not reported
- Accession: 0001072613-24-000469
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1701541/000107261324000469/nea16-bldiamond_18839.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701541/000107261324000469/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701541/000107261324000469/nea16-bldiamond_18839.htm

Filed May 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001072613-24-000469. Last ingested by Listed: Nov 10, 2026, 16:37 ET. No prices; not investment advice.
